What does CUSIP 558868105 represent in this 13F holders report?

CUSIP 558868105 is the security identifier for MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in Q4 2018?

130 institutional investors reported MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock for Q4 2018. Use the holders table for investor-level position and value details.

MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)

CUSIP: 558868105

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock
Shares outstanding: 22,766,960
Total 13F shares: 8,980,955
Share change: +360,639
Total reported value: $1,012,211,915
Put/Call ratio: 19%
Price per share: $112.72
Number of holders: 130
Value change: -$4,919,869
Number of buys: 68
Number of sells: 82

Quarterly Holders Quick Answers

What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 558868105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	7.3%	1,664,452	$356,409,000	—	30 Sep 2018	13F
BAKER BROS. ADVISORS LP	13F	Company	5.1%	1,169,278	$250,377,000	—	30 Sep 2018	13F
VANGUARD GROUP INC	13F	Company	3.1%	706,318	$151,243,000	—	30 Sep 2018	13F
BlackRock Finance, Inc.	13F	Company	2.5%	575,019	$123,130,000	—	30 Sep 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.2%	500,877	$107,253,000	—	30 Sep 2018	13F
Avoro Capital Advisors LLC	13F	Company	2%	463,000	$99,142,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	1.9%	428,269	$91,704,000	—	30 Sep 2018	13F
Rock Springs Capital Management LP	13F	Company	1.5%	342,000	$73,232,000	—	30 Sep 2018	13F
HealthCor Management, L.P.	13F	Company	1.2%	262,860	$56,286,000	—	30 Sep 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	0.98%	223,371	$47,830,000	—	30 Sep 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.93%	212,760	$45,558,000	—	30 Sep 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.85%	193,698	$41,476,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.45%	102,826	$22,019,000	—	30 Sep 2018	13F
OppenheimerFunds, Inc.	13F	Company	0.42%	95,830	$20,520,000	—	30 Sep 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.42%	94,800	$20,300,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.38%	85,980	$18,410,000	—	30 Sep 2018	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.35%	80,000	$17,130,000	—	30 Sep 2018	13F
Capital World Investors	13F	Company	0.32%	73,500	$15,739,000	—	30 Sep 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.31%	70,865	$15,174,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.29%	64,912	$13,899,000	—	30 Sep 2018	13F
NORGES BANK	13F	Company	0.27%	60,954	$13,052,000	—	30 Sep 2018	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.26%	59,900	$12,827,000	—	30 Sep 2018	13F
FMR LLC	13F	Company	0.23%	52,980	$11,344,000	—	30 Sep 2018	13F
Artal Group S.A.	13F	Company	0.22%	50,000	$10,707,000	—	30 Sep 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.19%	42,938	$9,195,000	—	30 Sep 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.18%	41,631	$8,914,000	—	30 Sep 2018	13F
GREAT POINT PARTNERS LLC	13F	Company	0.18%	40,400	$8,651,000	—	30 Sep 2018	13F
Bank of New York Mellon Corp	13F	Company	0.16%	37,482	$8,026,000	—	30 Sep 2018	13F
Man Group plc	13F	Company	0.15%	33,122	$7,091,000	—	30 Sep 2018	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.14%	33,000	$7,066,000	—	30 Sep 2018	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.14%	33,000	$7,066,000	—	30 Sep 2018	13F
MACQUARIE GROUP LTD	13F	Company	0.14%	32,700	$7,002,000	—	30 Sep 2018	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.14%	32,050	$6,863,000	—	30 Sep 2018	13F
ALPS ADVISORS INC	13F	Company	0.12%	27,194	$5,823,000	—	30 Sep 2018	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.12%	26,308	$5,633,000	—	30 Sep 2018	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.11%	25,887	$5,543,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	0.1%	21,683	$4,643,000	—	30 Sep 2018	13F
Pier Capital, LLC	13F	Company	0.09%	20,354	$4,358,000	—	30 Sep 2018	13F
MARSHALL WACE, LLP	13F	Company	0.09%	19,808	$4,241,000	—	30 Sep 2018	13F
SHIKIAR ASSET MANAGEMENT INC	13F	Company	0.07%	15,341	$3,285,000	—	30 Sep 2018	13F
Ghost Tree Capital, LLC	13F	Company	0.06%	14,200	$3,041,000	—	30 Sep 2018	13F
Atika Capital Management LLC	13F	Company	0.06%	14,000	$2,998,000	—	30 Sep 2018	13F
S.c.a. Candriam	13F	Individual	0.06%	13,950	$2,987,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.06%	13,749	$2,944,000	—	30 Sep 2018	13F
TD ASSET MANAGEMENT INC	13F	Company	0.06%	13,392	$2,868,000	—	30 Sep 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.06%	13,203	$2,827,000	—	30 Sep 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.06%	13,180	$2,822,000	—	30 Sep 2018	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.06%	12,746	$2,729,000	—	30 Sep 2018	13F
Informed Momentum Co LLC	13F	Company	0.06%	12,699	$2,719,000	—	30 Sep 2018	13F
Swiss National Bank	13F	Company	0.05%	12,500	$2,677,000	—	30 Sep 2018	13F

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q4 2018

As of 31 Dec 2018, MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) was held by 130 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,980,955 shares. The largest 10 holders included Capital Research Global Investors, BAKER BROS. ADVISORS LP, Vanguard Group Inc, HealthCor Management, L.P., STATE STREET CORP, BlackRock Inc., JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., JENNISON ASSOCIATES LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 130 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

153

Q4 2018 holders

130

Holder diff

-23

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.